The usage of HPC in life sciences is broad and multi-faceted. To efficiently use HPC resources and (more importantly) scientists’ time, pharmaceutical companies and other research organizations are pursuing consolidation and outsourcing, but successful implementation relies on high-performance data handling within a site and between sites. The SFA architecture from DDN addresses performance and scale within a site, creating a platform for efficient, high-performance data consolidation. And researchers worldwide are able to collaborate with WOS while avoiding barriers that restrict the usage of public cloud. With SFA and WOS, life sciences organization can continue to pursue their goals of both efficiency and discovery. To learn more download this white paper.